Pulmonary effects of i.v. injection of crushed oral tablets: "excipient lung disease".
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25341165.
- Also identified by DOI 10.2214/AJR.14.12582.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When crushed oral tablets are injected i.v., their filler material (excipient) can induce a potentially fatal foreign-body reaction in pulmonary arterioles, presenting as dyspnea and pulmonary hypertension with centrilobular nodules on CT. We will describe the imaging and pathologic features of "excipient lung disease." The radiologist has a critical role in recognizing and reporting excipient lung disease because the referring clinician may be unaware of the patient's i.v. drug abuse.
Medical subject headings
- Excipients
- Foreign-Body Migration
- Injections, Intravenous
- Lung Injury
- Substance Abuse, Intravenous